Barrier function of intact and impaired skin: Percutaneous penetration of caffeine and salicylic acid

International Journal of Dermatology

Volumn 50, Issue 7, 2011, Pages 881-889

  Rubio, Laia ^a   Alonso, Cristina ^a   López, Olga ^a   Rodríguez, Gelen ^a   Coderch, Luisa ^a   Notario, Jaime ^b   de la Maza, Alfonso ^a   Parra, José L ^a  

^a INSTITUTE OF ADVANCED CHEMISTRY OF CATALONIA IQAC CSIC   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; SALICYLIC ACID;

ANIMAL TISSUE; ARTICLE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; SKIN ABSORPTION; SKIN BIOPSY; SKIN DISEASE; SKIN PENETRATION; SKIN WATER LOSS; STRATUM CORNEUM;

ANIMALS; CAFFEINE; DERMIS; EPIDERMIS; KERATOLYTIC AGENTS; MODELS, BIOLOGICAL; PERMEABILITY; PHOSPHODIESTERASE INHIBITORS; SALICYLIC ACID; SKIN ABSORPTION; SURGICAL TAPE; SUS SCROFA; WATER;

EID: 79959576387     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2010.04819.x     Document Type: Article

References (44)

1. Elias PM. Stratum corneum defensive functions: an integrated view. J Invest Dermatol 2005; 125: 183-200.
2. Schaefer H, Redemeier TE. Skin Barrier - Principles of Percutaneous Absorption. Basel: Karger-Verlag, 1996.
3. Elias PM, Feingold KR. Stratum corneum barrier function: definitions and broad concepts. In: Elias PM, Feingold KR, ed. Skin Barrier. New York: Taylor and Francis Group, 2006: 1-4.
4. Bouwstra JA, Ponec M. The skin barrier in healthy and diseased state. Biochim Biophys Acta 2006; 1758: 280-295.
5. Fartasch M. The nature of the epidermal barrier: structural aspects. Adv Drug Deliv Rev 1996; 18: 273-282.
6. Kessner D, Ruettinger A, Kiselev MA, et al. Properties of ceramides and their impact on the stratum corneum structure. Part 2: stratum corneum lipid model systems. Skin Pharmacol Physiol 2008; 21: 58-74.
7. Howes D, Guy R, Hadgraft J, et al. Methods for assessing percutaneous absorption - the report and recommendations of ECVAM workshop 13. Altern Lab Anim 1996; 24: 81-106.
8. OECD. Guideline 428: skin absorption: in vitro method. In: Organisation for Economic Cooperation and Development, eds. OECD Guidelines for the Testing of Chemicals. Paris: OECD, 2004: 1-8.
9. OECD. Guidance document for the conduct of skin absorption studies number 28. In: Organisation for Economic Cooperation and Development, eds. OECD Series on Testing and Assessment. Paris: OECD, 2004: 9-31.
10. Williams A. Transdermal and Topical Drug Delivery: From Theory to Clinical Practice. London: Pharmaceutical Press, 2003.
11. Simon GA, Maibach HI. The pig as an experimental animal model of percutaneous permeation in man: qualitative and quantitative observations - an overview. Skin Pharmacol Appl Skin Physiol 2000; 13: 229-234.
12. Imokawa G, Abe A, Jin K, et al. Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? J Invest Dermatol 1991; 96: 523-526.
13. Paige DG, Morse-Fisher N, Harper JI. Quantification of stratum corneum ceramides and lipid envelope ceramides in the hereditary ichthyoses. Br J Dermatol 1994; 131: 23-27.
14. Motta S, Monti M, Sesana S, et al. Abnormality of water barrier function in psoriasis. Role of ceramide fractions. Arch Dermatol 1994; 130: 452-456.
15. Rawlings AV, Watkinson A, Rogers J. Abnormalities in stratum corneum structure, lipid composition and desmosome degradation in soap-induced winter xerosis. J Soc Cosmet Chem 1994; 45: 203-220.
16. Rogiers V. EEMCO guidance for the assessment of transepidermal water loss in cosmetic sciences. Skin Pharmacol Appl Skin Physiol 2001; 14: 117-128.
17. Rogiers V, Balls M, Basketter D, et al. The potential use of non-invasive methods in the safety assessment of cosmetic products. The report and recommendations of an ECVAM/EEMCO workshop (ECVAM workshop 36). Altern Lab Anim 1999; 27: 515-537.
18. Nangia A, Berner B, Maibach HI. Transepidermal water loss measurements for assessing skin barrier functions during in vitro percutaneous absorption studies. In: Bronaugh RL, Maibach HI, eds. Percutaneous Absorption: Drugs-Cosmetics-Mechanisms-Methodology. New York: Marcel Dekker, 1999: 587-594.
19. Sekkat N, Kalia YN, Guy RH. Porcine ear skin as a model for the assessment of transdermal drug delivery to premature neonates. Pharm Res 2004; 21: 1390-1397.
20. Sekkat N, Kalia YN, Guy RH. Development of an in vitro model for premature neonatal skin: biophysical characterization using transepidermal water loss. J Pharm Sci 2004; 93: 2936-2940.
21. Kalia YN, Nonato LB, Guy RH. The effect of iontophoresis on skin barrier integrity: non-invasive evaluation by impedance spectroscopy and transepidermal water loss. Pharm Res 1996; 13: 957-960.
22. Kalia YN, Alberti I, Sekkat N, et al. Normalization of stratum corneum barrier function and transepidermal water loss in vivo. Pharm Res 2000; 17: 1148-1150.
23. Rougier A, Lotte C, Maibach HI. In vivo relationship between percutaneous absorption and transepidermal water loss. In: Wester RC, Maibach HI, eds. Percutaneous Absorption: Drug-Cosmetics-Mechanisms-Methodology. New York: Marcel Dekker, 1999: 117-132.
24. Levin J, Maibach H. The correlation between transepidermal water loss and percutaneous absorption: an overview. J Control Release 2005; 103: 291-299.
25. Aalto-Korte K, Turpeinen M. Transepidermal water loss and absorption of hydrocortisone in widespread dermatitis. Br J Dermatol 1993; 128: 633-635.
26. Rougier A, Lotte C, Corcuff P, Maibach HI. Relationship between skin permeability and corneocyte size according to anatomic site, age and sex in man. J Soc Cosmet Chem 1988; 39: 15-26.
27. Tsai JC, Sheu HM, Hung PL, Cheng CL. Effect of barrier disruption by acetone treatment on the permeability of compounds with various lipophilicities: implications for the permeability of compromised skin. J Pharm Sci 2001; 90: 1242-1254.
28. Chilcott RP, Dalton CH, Emmanuel AJ, et al. Transepidermal water loss does not correlate with skin barrier function in vitro. J Invest Dermatol 2002; 118: 871-875.
29. Aalto-Korte K, Turpeinen M. Pharmacokinetics of topical hydrocortisone at plasma level after applications once or twice daily in patients with widespread dermatitis. Br J Dermatol 1995; 133: 259-263.
30. Bashir SJ, Dreher F, Chew AL, et al. Cutaneous bioassay of salicylic acid as a keratolytic. Int J Pharm 2005; 292: 187-194.
31. Vali A, Asilian A, Khalesi E, et al. Evaluation of the efficacy of topical caffeine in the treatment of psoriasis vulgaris. J Dermatolog Treat 2005; 16: 234-237.
32. Dias M, Hadgraft J, Lane ME. Influence of membrane-solvent-solute interactions on solute permeation in skin. Int J Pharm 2007; 340: 65-70.
33. Kalia YN, Nonato LB, Lund CH, Guy RH. Development of skin barrier function in premature infants. J Invest Dermatol 1998; 111: 320-326.
34. Lotte C, Rougier A, Wilson DR, Maibach HI. In vivo relationship between transepidermal water loss and percutaneous penetration of some organic compounds in man: effect of anatomic site. Arch Dermatol Res 1987; 279: 351-356.
35. Klimowicz A, Farfal S, Bielecka-Grzela S. Evaluation of skin penetration of topically applied drugs in humans by cutaneous microdialysis: acyclovir vs. salicylic acid. J Clin Pharm Ther 2007; 32: 143-148.
36. Nielsen JB. Percutaneous penetration through slightly damaged skin. Arch Dermatol Res 2005; 296: 560-567.
37. Nielsen JB, Nielsen F, Sorensen JA. Defense against dermal exposures is only skin deep: significantly increased penetration through slightly damaged skin. Arch Dermatol Res 2007; 299: 423-431.
38. Simonsen L, Fullerton A. Development of an in vitro skin permeation model simulating atopic dermatitis skin for the evaluation of dermatological products. Skin Pharmacol Physiol 2007; 20: 230-236.
39. Wu XM, Todo H, Sugibayashi K. Effects of pretreatment of needle puncture and sandpaper abrasion on the in vitro skin permeation of fluorescein isothiocyanate (FITC)-dextran. Int J Pharm 2006; 316: 102-108.
40. Feldmann RJ, Maibach HI. Absorption of some organic compounds through the skin in man. J Invest Dermatol 1970; 54: 399-404.
41. Franz TJ. Percutaneous absorption. On the relevance of in vitro data. J Invest Dermatol 1975; 64: 190-195.
42. Franz TJ, Lehman PA, Raney SG. Use of excised human skin to assess the bioequivalence of topical products. Skin Pharmacol Physiol 2009; 22: 276-286.
43. Herkenne C, Alberti I, Naik A, et al. In vivo methods for the assessment of topical drug bioavailability. Pharm Res 2008; 25: 87-103.
44. Gattu S, Maibach HI. Enhanced absorption through damaged skin: an overview of the in vitro human model. Skin Pharmacol Physiol 2010; 23: 171-176.